Account Executive at BillionToOne

Utah, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Diagnostics, Biotechnology, Precision MedicineIndustries

Requirements

Minimum three (3) years of outside field sales experience within the healthcare sector, directly calling upon providers in specified geographic territory
Demonstrated successful sales track record, understanding of buyer/decision maker types, exhibit effective selling, listening, presentation skills, and ability to assess and respond to customer needs (National awards a plus)
Excellent organizational and communication skills (written and verbal) with demonstrated ability to effectively present to both internal and external customers
Effective time management skills required with a demonstrated ability to assess and prioritize opportunity required
Exceptionally bright, flexible, self-motivated and results oriented with strong interpersonal and analytical skills and the ability to think strategically as well as execute tactically
Must act with a sense of urgency, with a focus on closing business
Ability to assess the needs of medical professionals and staff members with a focus on consultative sales, coordination of logistics, and problem solving
Strong desire to work in a startup environment and must work independently with an internal drive to be successful
Working knowledge and application of HIPAA laws, privacy, and ethics surrounding patient privacy and information
Demonstrated values and ethics that support BillionToOne's mission, goals, and professional code of conduct

Responsibilities

Increasing utilization of UNITY Fetal Risk Screen and driving market development through direct sales to individual OBGYNs, MFMs, and Genetic Counselors
Identifying, developing, and managing commercial relationships with key opinion leaders in medicine and other key healthcare professionals
Effectively prospecting and cultivating new business and maintaining key relationships
Identifying and capitalizing on commercial opportunities for growth within a specific region or geography – predominately in OBGYN, MFM, and GC clinics, as well as hospital systems and Federally Qualified Health Centers
Creating and implementing a strategic business plan to grow utilization quickly in your geography
Managing the full lifecycle of the product sales process, including new business development and lead generation
Attending local tradeshows, industry conferences and networking events

Skills

Diagnostic Sales

Genetic Testing Sales

NIPT

OBGYN Sales

MFM Sales

Genetic Counselors

Key Opinion Leaders

Field Sales

Market Development

Account Management

BillionToOne

Molecular diagnostics for prenatal and oncology testing

About BillionToOne

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair resolution, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne emphasizes accuracy, efficiency, and accessibility in molecular testing, providing diagnostic services directly to healthcare providers. Their goal is to positively impact healthcare by making molecular testing more reliable and available to everyone.

Menlo Park, CaliforniaHeadquarters

2016Year Founded

$380.2MTotal Funding

SERIES_DCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Competitive pay

Retirement savings package

Parental leave

Free snacks & lunches

Medical, dental, & vision premiums

On campus perks

Free-on-site EV charging

Risks

Emerging biotech startups could threaten BillionToOne's market share.

Rapid technological advancements may render their current technology obsolete.

Expansion into new facilities may face operational challenges or delays.

Differentiation

BillionToOne's QCT technology detects DNA variations at single base-pair resolution.

Their UNITY Fetal Antigen NIPT is the first US cfDNA test for fetal antigen genotyping.

They replace invasive amniocentesis with a safe, affordable blood test for prenatal screening.

Upsides

BillionToOne achieved a billion-dollar valuation with a $130 million funding round.

Their new Austin facility will create 1,000 jobs, boosting production and local economy.

Recognition as Diagnostics Company of the Year highlights their industry leadership.

Land your dream remote job 3x faster with AI

Try Jobo Free